Lower riskDrug recall · FDA · Published April 14, 2020
MasterPharm Finasteride Plus Capsules Contain Minoxidil - Cross Contamination Hazard
MasterPharm recalls 30-count and 90-count Finasteride Plus 1.25mg capsules that contain minoxidil due to cross contamination. This may cause unintended side effects. Consumers should contact the manufacturer for details.
“MasterPharm Finasteride Plus Capsules Contain Minoxidil - Cross Contamination Hazard.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37147-masterpharm-finasteride-plus-capsules-contain-minoxidil-cross-contamination-hazard. Based on FDA recall #D-1269-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1269-2020%22&limit=1).
The FDA announced on April 14, 2020, that MasterPharm LLC voluntarily recalled Finasteride Plus 1.25 mg Capsules due to cross-contamination with minoxidil. The agency classified the recall as Class I.
How to tell if you have it
Brand: MasterPharm
Product: Finasteride Plus 1.25 mg Capsule
Packaging: 30-count bottle, 90-count bottle
Lot #: 02-27-2020:04@11
Expiration Date: August 25, 2020
The hazard
Finasteride Plus 1.25mg capsules were found to contain minoxidil, constituting a cross-contamination hazard. The FDA classified the recall as Class I.
Context
GovInfoNow's records show MasterPharm LLC has two other recalls on record since June 9, 2020, including a July 2, 2020, recall for lack of processing controls and a June 9, 2020, recall for elevated drug content. Other recent recalls of similar products include Golden State Medical Supply Primidone Tablets Recall (April 27, 2026), Lannett Primidone Tablets Recall (April 24, 2026), and Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall (November 21, 2025).
How to tell if you have this one
Check for 30-count or 90-count bottles of Finasteride Plus 1.25mg capsules with lot number 02-27-2020:04@11 and expiration date August 25, 2020.
Brand
MasterPharm
Category
Drug
Based on the official FDA remedy
What to do — step by step
Contact Manufacturer
Reach out to MasterPharm at 115-02 Liberty Ave, Richmond Hill, NY 11419 for specific instructions on handling the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.4 years after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1269-2020 (April 14, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1269-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.